Article Information
History
- August 29, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zicheng Hu1,2,*,
- Kattria van der Ploeg3,
- Saborni Chakraborty3,
- Prabhu Arunachalam4,
- Diego Martinez Mori3,
- Karen B. Jacobson3,
- Hector Bonilla3,
- Julie Parsonnet3,5,
- Jason Andrews3,
- Haley Hedlin6,
- Lauren de la Parte3,
- Kathleen Dantzler3,
- Maureen Ty3,
- Gene S Tan7,
- Catherine A. Blish3,8,
- Saki Takahashi9,
- Isabel Rodriguez-Barraquer9,
- Bryan Greenhouse8,9,
- Atul J. Butte1,
- Upinder Singh3,10,
- Bali Pulendran4,10,11,
- Taia T. Wang3,10 and
- Prasanna Jagannathan3,10,*
- 1Bakar Computational Health Sciences Institute, University of California, San Francisco
- 2Department of Microbiology and Immunology, University of California, San Francisco
- 3Department of Medicine, Stanford University
- 4Institute for Immunity, Transplantation, and Infection, Stanford University, Stanford, CA, USA
- 5Department of Epidemiology and Population Health, Stanford University, Stanford CA, USA
- 6Quantitative Sciences Unit, Stanford University, Stanford, CA, USA
- 7J. Craig Venter Institute, San Diego, USA
- 8Chan Zuckerberg Biohub, San Francisco, CA
- 9Department of Medicine, University of California, San Francisco
- 10Department of Microbiology and Immunology, Stanford University
- 11Department of Pathology, Stanford University, Stanford CA, USA
- ↵*Corresponding authors Zicheng Hu, 490 Illinois Street, San Francisco CA 94158, Prasanna Jagannathan, 240 Pasteur Drive Room 3456, Stanford CA 94305 email: hzc363{at}gmail.com
Posted August 29, 2021.
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19
